During the past decade, N.N. Blokhin Russian Cancer Research Center conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 17 clinical trials were completed, i.e. on average, 73.9% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 8 clinical trials were completed. i.e. 61.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "N.N. Blokhin Russian Cancer Research Center" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Kidney Cancer Research Bureau" with 4 trials sponsored, "Blokhin's Russian Cancer Research Center" with 3 trials sponsored, "MelanomaPRO, Russia" with 3 trials sponsored and "Astellas Pharma Inc" with 3 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "N.N. Blokhin Russian Cancer Research Center" #1 collaborator was "Basilea Pharmaceutica" with 1 trials as a collaborator, "Basilea Pharmaceutica International Ltd" with 1 trials as a collaborator, "Blokhin's Russian Cancer Research Center" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "N.N. Blokhin Russian Cancer Research Center" are "Melanoma" (5 trials), "Melanoma (Skin)" (3 trials), "Rectal Cancer" (3 trials), "Rectal Neoplasms Malignant" (3 trials) and "Rectum Carcinoma" (3 trials). Many other conditions were trialed in "N.N. Blokhin Russian Cancer Research Center" in a lesser frequency.

Most popular intervention types in "N.N. Blokhin Russian Cancer Research Center" are "Drug" (34 trials), "Biological" (5 trials), "Procedure" (5 trials), "Radiation" (5 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Radiotherapy" (4 trials), "Capecitabine" (3 trials), "Carboplatin" (3 trials) and "Cyclophosphamide" (3 trials). Other intervention names were less common.

The vast majority of trials in "N.N. Blokhin Russian Cancer Research Center" are 37 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "N.N. Blokhin Russian Cancer Research Center". undefined are not yet recruiting, 7 are recruiting, 6 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 17 completed trials in N.N. Blokhin Russian Cancer Research Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in N.N. Blokhin Russian Cancer Research Center, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".

N.N. Blokhin Russian Cancer Research Center has several departments that took part in Clinical trials: "Portuguese Oncology Institute - Coimbra" - 5 trials, "Tatarstan Cancer Cente" - 4 trials, "National Specialized Hospital for Active Oncology Treatment; Dermatology Clinic" - 2 trials